chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chief Complaint   pt c/o left facial droop starting today, states received 1st dose of Pfizer vaccine on 4/16. denies any other symptoms  History of Present Illness     59 yo WM here with left facial droop noted by his wife this PM when coming home, wife is a NP. No other symptoms  Pt noted that he was recent vaccinated at the megasite Friday, as noted above.  Denies:  Nausea vomiting  headache  chest pain SOB  falls  head trauma  changes in vision, double vision  falls  recent illness  new medications change in sleep patterns  tinnitus  history of:  heavy caffeine use  heavy alcohol use  trauma  stroke in the past  exposed to meningitis  BCP   Gen AAOx3NAD PERRLA EOMI, lids intact able to close without issue  Neck Supple, no bruits, no JVD appreciated cervical LNno lymphadenopathy CV +s1/s2 RRno RRG PulmCTA bilaterally no RRW Absoft NT/ND no RRGCVA  Extremities no edema, radial pulse intact  CN 2-12 intact, mm strength UE and LE 5/5, patellar reflex 2/4; no gait disturbance  very settle facial droop noted at the left lip, evident at resting and with laughter, not with induced smiling      Review of Systems     as above  Physical Exam  Vitals & Measurements  Temperature Temporal: 97.5 DEGF Systolic Blood Pressure Cuff: 136 mmHg Diastolic Blood Pressure Cuff: 84 mmHg Peripheral Pulse Rate: 93 BPM Oxygen Saturation: 97 % Respiratory Rate: 16 BR/MIN WT (Kgs): 72.6 kg Weight Calculated (lbs): 160.054 LBS HT (In): 68 INCH     as above  Assessment/Plan      1 .   Left-sided Bell's palsy ( G51.0 )   Grade 2 very mild but has slight noticeable lip paraylsis  treat with high dose steroids as rec, eat with it  fu in 7 days with PCP supportive care  please see the clinical summary (includes immunizations), patient instructions and other supporting documents - as these are supplements to the SOAP note and should be reviewed as apart of the chart. Education provided- verbal, as well as any patient instructions printed.   Ordered:   predniSONE 20 mg oral tablet, 60 mg 3 TAB, Oral, Daily, X 7 DAYS, # 21 TAB, 0 Refill(s): 172.72, 04/20/21 18:21:00 EDT, Height Calculated (cm), cm, 72.6, 04/20/21 18:21:00 EDT, WT (Kgs), kg
101 Fever; chills; headache; body aches; fatigue; This is a spontaneous report received from a contactable consumer or other non hcp. A 75-years-old non-pregnant female patient received BNT162B2, (formulation: solution of injection), dose 2 via an unspecified route of administration, administered in Right Arm on 01Mar2021 14:30 (Batch/Lot Number: EN6205) as single dose for covid-19 immunisation. Medical history included, asthma from an unknown date and unknown if ongoing, depression from an unknown date and unknown if ongoing, hypothyroidism from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took avelox and experienced drug hypersensitivity, amoxicillin and experienced drug hypersensitivity, vicodin and experienced drug hypersensitivity.The patient previously received first dose BNT162B2 (formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 08feb2021 02:30 (Batch/Lot number:EL9262) as single dose for covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. the patient did not receive any other vaccine in four weeks.On 02Mar2021 07:00 AM, the patient experienced 101 fever, chills, headache, body aches and fatigue.The patient did not receive any treatment for the events. the clinical outcome for all the events was recovering.  No follow-up attempts are possible. No further information is expected.
Huge swollen underarm lymph node in same arm as vaccine. Swelling did not subside with time. Sought medical attention approx 14 days later
I got the shot around 10am. Very achy writes, hands and elbows. I was moaning during sleep per my husband. Low fever. I got up to use the bathroom and got very dizzy. I fainted and fell onto bed. My husband said I wasn't talking coherently.
Mother calls and reports no temperature, cranky, tired, sleepy, "he jerked a couple of times". I don't know if it was a seizure or not, "he went right to sleep afterwards and he slept about 1 hour. Mom called MD's office and he was closed. MD called mom, mom did not call him. She called H. U. and it was closed. Mom called H. U. the next day. Baby was fine.
Difficulty breathing which is getting worse.  Had to retire as could no longer do job.  Breathing and lung compactor continues to decline.  My doctor says result of inflammation but nothing has helped.  Current test show 50% capacity on exhale.  May also have esophagus issues as a result due for endoscopy with next month.
pt recv vax 9SEP96 & inj site area became very red & feverish the same day;rxn lasted about 2 days;pt recovered;
C/o localized swelling, lump and fever in arm. Within 1 hr of injection, Tylenol, or ibuprofen, ice pack to arm. Improved by afternoon of this day (9/10/04)
Headache; injection site was sufficiently sore; head to toe body aches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), VACCINATION SITE PAIN (injection site was sufficiently sore) and MYALGIA (head to toe body aches) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), VACCINATION SITE PAIN (injection site was sufficiently sore) and MYALGIA (head to toe body aches). At the time of the report, HEADACHE (Headache), VACCINATION SITE PAIN (injection site was sufficiently sore) and MYALGIA (head to toe body aches) had resolved. Not Provided          No concomitant medication was provided  Treatment medication was not provided by the reporter  Reporter was informed by my father on 10Oct2021 that a close family friend received a Moderna Covid-19 booster (third shot) from his local health department. The patient (SW, male) is likely in his 70s and  it had been >8months since his second shot. Patient had more severe side effects than the second shot. He got the shot Thursday am and had a headache by 10 pm. The injection  site was sufficiently sore to avoid all contact and he had head to toe body aches all through the night. Symptoms reduced by Friday am and were completely gone by Friday evening.   This case was linked to MOD-2021-350359 (Patient Link).
Pt reports he started shaking all over on 2/6/21 and it gradually improved over the next week.  He continues to experience problems with short term memory and recall.  Headaches, myalgias/arthralgias.  Positive for mild nausea, constipation.  Dizziness with turning his head started on 2/6/21 but has now resolved.
Fever a few hours after vaccine administered. Fever of aprox 105.0  Fahrenheit for 5 days. Pt fainted 2 times on 3/16/10. Rash on face and chest developed on 3/15/10.
A nurse reported that an adult female inadvertently received an ID injection of Tetanus Toxoid Adsorbed on 7/14/00. On 7/15/00, she developed redness at the injection site. She recovered within 3 days. The reporter indicated that 2 pts experienced this event; however, only 1 person has been identified.
Very painful and hot injection site day one. Day 2 had fever, chills, headache, muscle aches and lethargy as well as the painful arm. Day 3 painful arm and red rash at and around the injection. At the injection site there appears to be a blister.
temperature; fatigue; overall malaise; This is a spontaneous report from a contactable consumer. A female patient of an unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 03Apr2021 as a single dose for COVID-19 immunisation. Medical history was not reported. It was unknown if the patient received other medications in two weeks. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, it was unknown, if the patient was diagnosed with COVID-19. It was unknown if the patient had tested for COVID-19 since having the vaccine. On 04Apr2021, the patient experienced temperature, fatigue and overall malaise. It was unknown if the patient received treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events temperature, fatigue, and malaise was recovered on an unspecified date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Weakness in hands/ it is hard to hold coffee cup; Forearm pain/ arm pain for one day; Ongoing pain for months in upper right arm/upper arm pain that goes up to top of arm from her forearm down to hands/ pain is constant; Received 2nd booster dose; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Weakness in hands/ it is hard to hold coffee cup), PAIN IN EXTREMITY (Forearm pain/ arm pain for one day), VACCINATION SITE PAIN (Ongoing pain for months in upper right arm/upper arm pain that goes up to top of arm from her forearm down to hands/ pain is constant) and EXTRA DOSE ADMINISTERED (Received 2nd booster dose) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Levaquin), Drug allergy (steroids), Allergy to animals (cats), Allergy to animals (dogs), Drug allergy (OTC allergy) and COPD. Concomitant products included SALBUTAMOL (ALBUTEROL HFA) and IPRATROPIUM for COPD.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Nov-2021, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Nov-2021, the patient experienced MUSCULAR WEAKNESS (Weakness in hands/ it is hard to hold coffee cup), PAIN IN EXTREMITY (Forearm pain/ arm pain for one day), VACCINATION SITE PAIN (Ongoing pain for months in upper right arm/upper arm pain that goes up to top of arm from her forearm down to hands/ pain is constant) and EXTRA DOSE ADMINISTERED (Received 2nd booster dose). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 10-Nov-2021, PAIN IN EXTREMITY (Forearm pain/ arm pain for one day) had resolved. At the time of the report, MUSCULAR WEAKNESS (Weakness in hands/ it is hard to hold coffee cup) and EXTRA DOSE ADMINISTERED (Received 2nd booster dose) outcome was unknown and VACCINATION SITE PAIN (Ongoing pain for months in upper right arm/upper arm pain that goes up to top of arm from her forearm down to hands/ pain is constant) had not resolved.            The patient was taking Clor Tabs as concomitant for OTC allergy.  The patient have never tested positive for COVID-19.  Other vaccines were reported as none  Patient also had used heating pads for treatment.   This case was linked to MOD-2022-504401 (Patient Link).
Patient developed Belly palsy with right side facial droop after receiving 2nd shot of her Moderna vaccine
March 13 Fever 12 hours post vaccine. One week later tingling and numbness needle pin pain in finger tips which then proceeded to move up the arm. 2 weeks after same feeling in feet along with muscle spasms in buttocks and calf muscles.  March 28 could not hardly move. March 29 went to hospital reported symptoms tests were run legs and arms numb pins needles and then felt like they were on fire.  I was told to watch symptoms at home.  That Wednesday went back to hospital ran all kind of Tests was told it was how my body is responding to vaccine and no one knows when I will be better. Discharged April 6 I need a Walker and assistance with everything still have the same symptoms. I have been given steroids muscle relaxer b12 and PT at home.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 23Sep2022 as dose 5 (booster), single (Batch/Lot number: Not available/provided to reporter at the time of report completion) at the age of 29 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Lupus" (unspecified if ongoing); "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Nuvigil, reaction(s): "Drug allergy"; Provigil, reaction(s): "Drug allergy".  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient received Paxlovid as treatment drug from 04Oct2022 to 09Oct2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt reports numbness to fingers of (L) hand and states drops things that she is holding with (L) hand. Pt states feels abscess to (L) forearm.
The initial case was missing the following minimum criteria: Unspecified number of patients. Upon receipt of follow-up information on 31May2018, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable physician via a Pfizer sales representative. This physician reported similar events for 3 patients. This is third of three reports. A female patient of an unspecified age (more than 65 years old) received PREVNAR 13, via an unspecified route of administration from an unspecified date at single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced oval shaped red patch with red dot under injection site on an unspecified date after pneumococcal 13-val conj vac (dipht crm197 protein) received. The outcome of event was unknown. The information on the lot number has been requested. Sender's Comments: Linked Report(s): US-PFIZER INC-2018225880 same reporter and suspect drug, similar event in different patients;US-PFIZER INC-2018225881 same reporter and suspect drug, similar event in different patients.
This case was reported by a healthcare professional via a sales representative, and described the occurrence of decreased therapeutic response in a subject of unspecified age and gender who was vaccinated with Pediarix for prophylaxis. The subject had reportedly received "Deptacel" on unspecified date(s). On an unspecified date the subject received the third dose of Pediarix (unknown). At an unspecified time after vaccination with Pediarix, the subject experienced decreased therapeutic response. The reporter indicated that "about 50 percent of patient ['s] ... levels of tetanus are below 0.1". It was noted that the subject required revaccination for tetanus, although medical attention was not required. At the time of reporting the outcome of the event was unspecified.
An hour later started feeling tired. Two hours after the injection had uncontrollable shaking in my hands and legs. Six hours after injection extreme dizziness a non stop roller coaster ride feeling and photosensitive with everything appearing blurry and foggy.  This feeling last the remainder of the night. The second day I the have very made vertigo. The entire day felt like being on a ship in the middle of a storm. With pain in all my joints, my back and chest. Photophobia was still bad. The third fourth and fifth day after the injection was waking up in a pool of sweat, the feeling of being on a ship, slight dizziness, slight nausea, loss of appetite, and headache. The
tingling of feet and face; He had his Inflectra infusion, three days after his first shot of the Pfizer COVID19 vaccine; Stated that his cal protectnin number jumped up after he got the vaccine; This is a spontaneous report received from a contactable reporter. A 16-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot number and expiration date not reported), via an unspecified route of administration on an unspecified date, as a single dose for COVID-19 immunization. Medical history included cal protectnin. Concomitant medications were not reported. Caller was calling for her son that is also on Inflectra. He got his first dose of the Pfizer BioNTech COVID19 vaccine. He had his Inflectra infusion, three days after his first shot of the Pfizer COVID19 vaccine. He has his second dose on Friday, and she is wondering if it is safe to get his second dose at 21 days or if he should wait longer. It seems that she is asking if there was an interaction. She later mentions that after his first dose of the COVID19 vaccine he had a reaction: tingling of feet and face. Caller states that she was very frustrated with us. She feels like we're not providing her with the information she needs, and she has to make a tough decision for her child. Both are our medicines (Inflectra and Pfizer COVID19 vaccine) and we should have this information. Patient that stated that her son had Pfizer Vaccine for Covid earlier in the month and three days after had an Inflectra infusion. Stated that he is coming up for an appointment for another Inflectra infusion which is 3 weeks later. Wanted to know if he should get the vaccine again and if it was too much in a given time frame. Clarified that his infusions are eight weeks apart. Stated that the pharmacy told her that he was to not take any other medication with the Inflectra which made her hesitant. Stated that they did the vaccine and was told by the doctor it was okay. Wanted to know how long to wait between first and second vaccine knowing he had an infusion three weeks after it. Wanted to know if it was 42 days in-between. Stated that his cal protectnin number has been going down since October. Stated that his cal protectnin number jumped up after he got the vaccine. Stated that it was not greater than 8000 and has gradually decreased. Wanted to know if they should wait longer for second for the second vaccine to make sure that it was not messing with his Inflectra. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a physician via company employees and a practice manager referring to a patient of unknown age and gender. On 12-FEB-2015 the patient was vaccinated with an improperly stored dose of M-M-R II 0.5ml (rHA (recombinant human albumin), lot #J014876, expiration date 21-NOV-2015, dose and route were unspecified). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 48 hours with the lowest recorded temperature of 32 Fahrenheit degree. The storage criteria of this vaccine was refrigerator/freezer (R/F) and the type of excursion was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Approximately around 3 months after my booster shot, I tested positive for COVID and experienced the following symptoms: Fatigue, Phlegm in my throat, Head congestion and Brain fog. I took Dayquil and Nyquil for treatment, and my symptoms lasted for 2 weeks overall except for my Brain fog which lasted for about 3-4 weeks.
Pharmacist unknowingly pulled vaccine from package with expired beyond-use-date. Vaccine administered to the patient 7 days past beyond-use-date. No adverse events reported.
Nine days after receiving flu vaccination I came down with severe muscle pain, fever, weakness in my joints, and partial numbness in my feet and hands with also some loss of movement and loss of strength. At one point I was unable to get up from a reclining or sitting position for about a day. After some blood tests and three visits to my physician the diagnosis of 'serum sickness' and Guillain Barre syndrome was given. I have begun to recover but I still residual pain in my muscles and loss of manual dexterity in my fingers. 10/23/09 Medical records received for dates 9/24/09 to 9/30/09. Pt presented to office on 9/24/09 c/o HA, muscle pain, dysphagia, dyspnea, fever, diarrhea after receiving flu vax. PE WNL. DX viremia. 9/26/09 Pt. presented with muscle pain x2-3days, fever, trouble walking up stairs due to pain, arm pain, shortness of breath. PE WNL. DX: myalgia, probably viral syndrome, does not look like GBS. 9/30/09 Pt presented with c/o loss of movement in legs, lost coordination, strength in legs and hands. DX: reaction serum. ICD9 codes: 999.5, 729.1, 790.8
little bit of headache; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. This female patient of an unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 24Mar2021 as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. On 24Mar2021, the patient was experiencing a little bit of headache and wants to know if she can take Tylenol. The clinical outcome of "a little bit of headache" was unknown.  No follow-up attempts are needed; information about batch/lot number cannot be obtained. No further information is expected.
Fever, chills, severe vomiting, extreme body aches to the point she felt she might have to go to the Emergency room. Lasted until 2/3/16.
Pt received Janssen primary dose. Presented today for booster. Chose to have Moderna booster. Pt was given 0.5ml dose instead of 0.25ml booster dose. Error.
Per mother after receiving injection , she picked up rx from pharmacy, went to car notice red rash approx. 15 mins after receiving injection. Mother left clinic and went home. returning later to urgent care center.
Pt rec. vaccine on 4/5/13. Sat. The next Tuesday pt developed jaw pain and saw dentist. Shingles developed on face and in mouth.
Received Influenza and Pneumonia vaccine 10-18-07. Stated she had chills, 102 F fever, headache and could not raise arm the night of 10-18-07. 10-19-07 she had low grade fever, pain at site, dizzy. Headache and arm blotchy red and swollen. 10-22-07 States she feels better. Arm slightly swollen.